12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We determine if intravesical bacillus Calmette-Guerin (BCG) reduces the risk of progression after transurethral resection to stage T2 disease or higher in patients with superficial (stage Ta, T1 or carcinoma in situ) bladder cancer.

          Related collections

          Author and article information

          Journal
          J. Urol.
          The Journal of urology
          Ovid Technologies (Wolters Kluwer Health)
          0022-5347
          0022-5347
          Nov 2002
          : 168
          : 5
          Affiliations
          [1 ] European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium.
          Article
          S0022-5347(05)64273-5
          10.1097/01.ju.0000034450.80198.1c
          12394686

          Comments

          Comment on this article